---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-036848"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:03:06.409704+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Elicio Therapeutics closes $20M convertible note private placement at $5.81 conversion price

## Summary
- Raised $20M via 3% senior secured convertible note due Feb 2026; net proceeds ~$19.7M.
- Conversion price $5.81 per share (~135% of Aug 9 close); subject to stockholder approval.
- Purchaser GKCC LLC is controlled by a board member (related-party transaction).
- Proceeds to be used for working capital and general corporate purposes.
- Note is secured by first-priority lien on substantially all assets and intellectual property.

## SEC filing metadata
- accession: 0001140361-24-036848
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/0001140361-24-036848-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/ef20033947_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-036848
- JSON: https://secwatch.observer/filing/0001140361-24-036848.json
- Plain text: https://secwatch.observer/filing/0001140361-24-036848.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.